Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Bioequivalence Data: Statistical Interpretation

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...

Introduction to Epidemiology

Introduction to Epidemiology

Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Consensus Guidelines for Staging and Surveillance Imaging in Cutaneous Squamous Cell Carcinoma.

JAMA dermatology·2026

Same author

Neil A. Swanson, M.D. (1949-2025).

Journal of the American Academy of Dermatology·2025

Same author

Interrater and Intrarater Reliability of Mohs Surgeons in the Assessment of MART-1 Frozen Section Margins for Melanoma.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2025

Same author

Disparities in online patient education materials for rheumatic skin diseases.

The British journal of dermatology·2025

Same author

Group coaching for career development: Supporting the endangered early career researcher.

Journal of clinical and translational science·2025

Same author

Validation of CXCL9 as a biomarker of morphoea disease state and severity through longitudinal analysis.

The British journal of dermatology·2025

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Understanding clinical trial outcomes: design, analysis, and interpretation.

Heidi T Jacobe¹, Justin J Leitenberger, Paul R Bergstresser

¹Department of Dermatology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390-9069, USA. heidi.jacobe@utsouthwestern.edu

Dermatologic Therapy

|June 1, 2007

Summary

Clinical trial outcomes are crucial but lack consensus in dermatology, potentially invalidating results. This study reviews outcome types and analysis for better trial design and interpretation.

Related Experiment Videos

Last Updated: Jul 14, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Area of Science:

Dermatology
Clinical Trials
Biostatistics

Background:

Outcome measures are essential for clinical trial design, conduct, and analysis.
Four main categories of outcomes exist: physician-based, patient-reported, economic-based, and technology-based.
A lack of consensus on outcome selection and validation in dermatology can compromise trial integrity.

Purpose of the Study:

To provide an overview of key considerations for selecting and utilizing outcome measures in dermatological clinical trials.
To offer a practical approach to the analysis of outcome data in dermatology research.
To address the need for standardized and validated outcome measures in dermatological studies.

Main Methods:

Literature review of outcome measure categories and their application in dermatology.
Discussion of the importance of outcome quality and validation.
Exploration of practical analytical approaches for different outcome types.

Main Results:

Dermatology utilizes various outcome types, but consensus on their use and validation is absent.
Inappropriate outcome selection or application can lead to invalid clinical trial results.
Standardized outcome measures are needed to improve the reliability of dermatological research.

Conclusions:

Standardizing outcome measures and their validation is critical for robust dermatological clinical trials.
A clear understanding of outcome types and analytical methods is necessary for researchers.
Further attention to outcome measures will enhance the quality and interpretability of dermatological evidence.